Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma

BACKGROUND: Exploration of serum biomarkers for early detection of upper gastrointestinal cancer is required. Here, we aimed to evaluate the diagnostic potential of serum desmoglein-2 (DSG2) in patients with esophageal squamous cell carcinoma (ESCC) and esophagogastric junction adenocarcinoma (EJA)....

Full description

Bibliographic Details
Main Authors:	Chu, L.-Y (Author), Fang, W.-K (Author), Liu, Y.-Q (Author), Xie, J.-J (Author), Xu, Y.-W (Author), Yang, T. (Author), Zhang, B. (Author), Zheng, Z.-T (Author)
Format:	Article
Language:	English
Published:	NLM (Medline) 2022
Subjects:	diagnosis DSG2 esophageal squamous cell carcinoma esophagogastric junction adenocarcinoma serum biomarker
Online Access:	View Fulltext in Publisher

Similar Items

Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma
by: Tamar Nobel, et al.
Published: (2019-07-01)

Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study
by: Yu Imamura, et al.
Published: (2021-01-01)

Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
by: Haitao Xu, et al.
Published: (2020-06-01)

Comparison of short‐term outcomes following minimally invasive versus open Sweet esophagectomy for Siewert type II adenocarcinoma of the esophagogastric junction
by: Xiaohui Sun, et al.
Published: (2020-06-01)

Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction
by: Peng Defeng, et al.
Published: (2016-01-01)

Combined Extensive Esophageal Squamous Papillomas and Florid Cardiac Gland Hyperplasia in a Patient with Adenocarcinoma
by: Takanori Suganuma, et al.
Published: (2017-08-01)

HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma
by: Zhao Yang Wang, et al.
Published: (2021-03-01)

How to decide surgical procedure for esophagogastric junction cancer?
by: Yasuyuki Seto, et al.
Published: (2020-02-01)

The Association Between Immune Characteristic and Clinical Pathology in Chinese Patients with Adenocarcinoma of Esophagogastric Junction
by: Wang Y, et al.
Published: (2020-05-01)

Prognostic significance of preoperative albumin-to-globulin ratio and prognostic nutritional index combined score in Siewert type 3 adenocarcinoma of esophagogastric junction
by: Wang Y, et al.
Published: (2019-08-01)

Comparative analysis of laparoscopic proximal gastrectomy plus semi-embedded valve anastomosis with laparoscopic total gastrectomy for adenocarcinoma of the esophagogastric junction: a single-center retrospective cohort study
by: Yupeng Wu, et al.
Published: (2021-02-01)

miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case–control study involving 2,740 participants
by: Chen Y, et al.
Published: (2018-06-01)

Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV
by: Keiko Yamamoto, et al.
Published: (2020-01-01)

A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report
by: Takako Tanaka, et al.
Published: (2020-01-01)

Expression of Programmed Cell Death 1 and Lymphocyte Activation Gene 3 in Perioperation of Adenocarcinoma of Esophagogastric Junction and Related Significance
by: ZHANG Wei, et al.
Published: (2019-05-01)

Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
by: Seyed Amir Aledavood, et al.
Published: (2021-04-01)

Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery
by: Zheng C, et al.
Published: (2020-12-01)

Renal cell carcinoma metastasizing to adenocarcinoma of esophagogastric junction: A rare case of tumor-to-tumor metastasis
by: Renu Sukumaran, et al.
Published: (2012-01-01)

Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction
by: Qifan Yin, et al.
Published: (2019-11-01)

Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study
by: Yiding Feng, et al.
Published: (2020-11-01)

Paget’s disease derived in situ from reserve cell hyperplasia, squamous metaplasia, and squamous cell carcinoma of the esophagogastric junction: a case report
by: Akihiko Sano, et al.
Published: (2018-07-01)

Association of miRNA-499 rs3746444 A>G variants with adenocarcinoma of esophagogastric junction (AEG) risk and lymph node status
by: Tang W, et al.
Published: (2019-08-01)

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
by: Wang Wen-Ping, et al.
Published: (2012-01-01)

Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction
by: Lu X, et al.
Published: (2016-07-01)

Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation
by: Tongbo Wang, et al.
Published: (2021-01-01)

Adenocarcinoma da transição esofagogástrica: análise multivariada da morbimortalidade cirúrgica e terapia adjuvante Esophagogastric junction adenocarcinoma: multivariate analyses of surgical morbi-mortality and adjuvant therapy
by: Valdir Tercioti-Junior, et al.
Published: (2012-12-01)

Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma
by: Ying Wang, et al.
Published: (2021-03-01)

Acute Anisakiasis at the Esophagogastric Junction Mimicking Angina Pectoris
by: Dong Chan Joo, et al.
Published: (2021-06-01)

Accuracy of Preoperative Endoscopy in Determining Tumor Location Required for Surgical Planning for Esophagogastric Junction Cancer
by: Koichi Okumura, et al.
Published: (2021-07-01)

Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction
by: Jianping Xiong, et al.
Published: (2020-12-01)

Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction
by: Xin Hu, et al.
Published: (2021-05-01)

Short-Term and Long-Term Outcomes Following Transhiatal versus Right Thoracoabdominal Resection of Siewert Type II Adenocarcinoma of the Esophagogastric Junction
by: Xing J, et al.
Published: (2020-11-01)

Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report
by: Miho Yamamoto, et al.
Published: (2018-06-01)

Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data
by: Jian Chen, et al.
Published: (2021-05-01)

Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis
by: Jing Li, et al.
Published: (2021-03-01)

Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report
by: Kenichiro Furukawa, et al.
Published: (2020-01-01)

Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China
by: Baoyu Zhao, et al.
Published: (2019-01-01)

Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study
by: Ito Hiroaki, et al.
Published: (2013-01-01)

Retrospective Analysis of the Outcomes in Elderly Patients with Adenocarcinoma of the Stomach and Esophagogastric Junction Following Three Different Treatments
by: Thammawat Parakonthun, et al.
Published: (2019-11-01)

Molecular classification of esophagogastric junction carcinoma correlated with prognosis
by: Zou L, et al.
Published: (2017-09-01)